Skip to main content
. 2022 Jun 20;2(3):65–72. doi: 10.47936/encephalitis.2022.00024

Table 2.

Indications for telemedicine in epilepsy and encephalitis

No Epilepsy Encephalitis
1 Fully investigated etiology of epilepsy Fully investigated etiology of encephalitis
2 Completion of ASM dose titration Completion of immunotherapy
3 No breakthrough seizure in at least 3 months Improving or stable patients with controllable symptoms
Recommended for cognitive function evaluation
Recommended for psychiatric symptom evaluation and management

ASM, antiseizure medication.